Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mübeccel Akdis and Claus Bachert.
Mübeccel Akdis
Connection Strength
0.348
Claus Bachert
  1. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.056
  2. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.056
  3. Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma. Am J Respir Crit Care Med. 2018 12 15; 198(12):1490-1499.
    View in: PubMed
    Score: 0.050
  4. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019 04; 143(4):1403-1415.
    View in: PubMed
    Score: 0.049
  5. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
    View in: PubMed
    Score: 0.047
  6. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov; 140(5):1250-1267.
    View in: PubMed
    Score: 0.046
  7. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.